Elias Harold K, Mitra Sneha, da Silva Marina B, Rajagopalan Adhithi, Gipson Brianna, Lee Nicole, Kousa Anastasia I, Ali Mohamed A E, Grassmann Simon, Raghuraman Rhoshini, Zhang Xiaoqun C, DeWolf Susan, Smith Melody, Andrlova Hana, Argyropoulos Kimon V, Sharma Roshan, Fei Teng, Sun Joseph C, Dunbar Cynthia E, Park Christopher Y, Leslie Christina S, Bhandoola Avinash, Kharas Michael G, van den Brink Marcel R M
Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
National Institutes of Health (NIH), Bethesda, MD, USA.
Nat Commun. 2025 Jul 4;16(1):6170. doi: 10.1038/s41467-025-61125-1.
Hematopoietic stem cells (HSC) with multilineage potential are critical for T cell reconstitution after allogeneic hematopoietic cell transplantation (allo-HCT). The Kit HSC subset is enriched for multipotential precursors, but their T cell potential remains poorly characterized. Using a preclinical allo-HCT mouse model, we demonstrate that Kit HSCs provide superior thymic recovery and T cell reconstitution, resulting in improved immune responses to post-transplant infection. Kit HSCs with augmented bone marrow (BM) lymphopoiesis mitigate age-associated thymic alterations and enhance T cell recovery in middle-aged mice. Mechanistically, chromatin profiling reveals Kit HSCs exhibiting higher activity of lymphoid-specifying transcription factors, such as, ZBTB1. Zbtb1 deletion diminishes HSC engraftment and T cell potential; by contrast, reinstating Zbtb1 in megakaryocytic-biased Kit HSCs rescues hematopoietic engraftment and T cell potential in vitro and in vivo. Furthermore, age-associated decline in Kit HSCs is associated with diminished T lymphopoietic potential in aged BM precursors; meanwhile, Kit HSCs in aged mice maintain enhanced lymphoid potential, but their per-cell capacity is diminished. Lastly, we observe an analogous human BM KIT HSC subset with enhanced lymphoid potential. Our results thus uncover an age-related epigenetic regulation of lymphoid-competent Kit HSCs for T cell reconstitution.
具有多谱系分化潜能的造血干细胞(HSC)对于异基因造血细胞移植(allo-HCT)后的T细胞重建至关重要。Kit HSC亚群富含多能前体细胞,但其T细胞潜能仍未得到充分表征。利用临床前allo-HCT小鼠模型,我们证明Kit HSCs能提供卓越的胸腺恢复和T细胞重建,从而改善对移植后感染的免疫反应。具有增强骨髓(BM)淋巴细胞生成能力的Kit HSCs可减轻与年龄相关的胸腺改变,并增强中年小鼠的T细胞恢复。从机制上讲,染色质分析显示Kit HSCs表现出更高活性的淋巴特异性转录因子,如ZBTB1。Zbtb1缺失会减少HSC植入和T细胞潜能;相反,在巨核细胞偏向的Kit HSCs中恢复Zbtb1可在体外和体内挽救造血植入和T细胞潜能。此外,Kit HSCs与年龄相关的下降与老年BM前体细胞中T淋巴细胞生成潜能的降低有关;同时,老年小鼠中的Kit HSCs保持增强的淋巴潜能,但其单细胞能力降低。最后,我们观察到人类BM KIT HSC亚群具有类似的增强淋巴潜能。因此,我们的结果揭示了具有淋巴潜能的Kit HSCs在T细胞重建中与年龄相关的表观遗传调控。